Tissue distribution of N-acetyltransferase 1 and 2 catalyzing the N-acetylation of 4-aminobiphenyl and O-acetylation of N-hydroxy-4-aminobiphenyl in the congenic rapid and slow acetylator Syrian hamster

Molecular Carcinogenesis

Volumn 45, Issue 4, 2006, Pages 230-238

  Hein, David W ^a   Doll, Mark A ^a   Nerland, Donald E ^a   Fretland, Adrian J ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

Acetylation polymorphism; Bladder cancer; NAT2 genotype; Pancreatic cancer

Indexed keywords

4 AMINOBENZOIC ACID; 4 BIPHENYLAMINE; ACYLTRANSFERASE; AROMATIC AMINE; ARYLAMINE ACETYLTRANSFERASE; BIPHENYL DERIVATIVE; HYDROXYL GROUP; N ACETYLTRANSFERASE 1; N HYDROXY 4 BIPHENYLAMINE; SULFADIMIDINE; UNCLASSIFIED DRUG;

ACETYLATION; ACETYLATOR PHENOTYPE; ANIMAL TISSUE; ARTICLE; CANCER; CYTOSOL; ENZYME ACTIVITY; ENZYME MECHANISM; ENZYME POLYMORPHISM; GENE; GENE LOCUS; MALE; NAT2 GENE; NONHUMAN; PRIORITY JOURNAL; SYRIAN HAMSTER; TISSUE DISTRIBUTION;

ACETYLATION; AMINOBIPHENYL COMPOUNDS; ANIMALS; ARYLAMINE N-ACETYLTRANSFERASE; CATALYSIS; CELL LINE; CRICETINAE; CYTOSOL; ISOENZYMES; MALE; MESOCRICETUS; TISSUE DISTRIBUTION;

ANIMALIA; MESOCRICETUS AURATUS;

EID: 33645453469     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.20164     Document Type: Article

References (58)

1. Hein DW. Acetylator genotype and arylamine-induced carcinogenesis. Biochim Biophys Acta 1988;948:37-66.
2. Weber WW, Hein DW. N-Acetylation pharmacogenetics. Pharmacol Revs 1985;37:25-79.
3. Hein DW, Doll MA, Fretland AJ, et al. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms. Cancer Epidemiol Biomarkers Prev 2000;9:29-42.
4. Butcher NJ, Boukouvala S, Sim E, Minchin RF. Pharmacogenetics of the arylamine N-acetyltransferases. Pharmacogenomics J 2002;2:30-42.
5. Hein DW. Molecular genetics and function of NAT1 and NAT2: Role in aromatic amine metabolism and carcinogenesis. Mutat Res 2002;506-507:65-77.
6. Rodrigues-Lima F, Dupret JM. Regulation of the activity of the human drug metabolizing enzyme arylamine N-acetyltransferase 1: Role of genetic and non genetic factors. Curr Pharm Des 2004;10:2519-2524.
7. Hein DW, Doll MA, Fretland AJ, et al. Rodent models of the human acetylation polymorphism: Comparisons of recombinant acetyltransferases. Mut Res 1997;376:101-106.
8. Hein DW, Omichinski JG, Brewer JA, Weber WW. A unique pharmacogenetic expression of the N-acetylation polymorphism in the inbred hamster. J Pharmacol Exp Ther 1982;220:8-15.
9. Grant DM, Beer M, Blum M, Meyer UA. Monomorphic and polymorphic human arylamine N-acetyltransferases: A comparison of liver isozymes and expressed products of two cloned genes. Mol Pharmacol 1991;39:184-191.
10. Hein DW, Doll MA, Rustan TD, et al. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases. Carcinogenesis 1993;14:1633-1638.
11. Ferguson RJ, Doll MA, Rustan TD, Baumstark BR, Hein DW. Syrian hamster monomorphic n-acetyltransferase (NAT1) alleles: Amplification, cloning, sequencing, and expression in E. coli. Pharmacogenetics 1994;4:82-90.
12. Abu-Zeid M, Nagata K, Miyata M, et al. An arylamine acetyltransferase (AT-I) from Syrian golden hamster liver: Cloning, complete nucleotide sequence, and expression in mammalian cells. Mol Carcinogenesis 1991;4:81-88.
13. Ferguson RJ, Doll MA, Rustan TD, Hein DW. Cloning, expression, and functional characterization of rapid and slow acetylator polymorphic N-acetyltransferase encoding genes of the Syrian hamster. Pharmacogenetics 1996;6:55-66.
14. Stabbert R, Schafer KH, Biefel C, Rustemeier K. Analysis of aromatic amines in cigarette smoke. Rapid Commun Mass Spectrom 2003;17:2125-2132.
15. Luceri F, Pieraccini G, Moneti G, Dolara P. Primary aromatic amines from side-stream cigarette smoke are common contaminants of indoor air. Toxicol Ind Health 1993;9:405-413.
16. Chiang TA, Pei-Fen W, Ying LS, Wang LF, Ko YC. Mutagenicity and aromatic amine content of fumes from heated cooking oils produced in Taiwan. Food Chem Toxicol 1999;37:125-134.
17. National Toxicology Program. Report on Carcinogens. Eleventh Edition, United States Department of Health and Human Services, Public Health Service. 2005.
18. Yu MC, Skipper PL, Taghizadeh K, et al. Acetylator phenotype, aminobiphenyl-hemoglobin adduct levels, and bladder cancer risk in White, Black, and Asian men in Los Angeles, California. J Natl Cancer Inst 1994;86:712-716.
19. Williams JA. Single nucleotide polymorphisms, metabolic activation and environmental carcinogenesis: Why molecular epidemiologists should think about enzyme expression. Carcinogenesis 2001;22:209-214.
20. Hearse DJ, Weber WW. Multiple N-acetyltransferases and drug metabolism. Tissue distribution, characterization and significance of mammalian N-acetyltransferase. Biochem J 1973;132:519-526.
21. Ilett KF, Reeves PT, Minchin RF, Kinnear BF, Watson HF, Kadlubar FF. Distribution of acetyltransferase activities in the intestines of rapid and slow acetylator rabbits. Carcinogenesis 1991;12:1465-1469.
22. Turesky RJ, Lang NP, Butler MA, Teitel CH, Kadlubar FF. Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. Carcinogenesis 1991;12:1839-1845.
23. Kirlin WG, Ogolla F, Andrews AF, et al. Acetylator genotype-dependent expression of arylamine N-acetyltransferase in human colon cytosol from non-cancer and colorectal cancer patients. Cancer Res 1991;51:549-555.
24. Ilett KF, Ingram DM, Carpenter DS, et al. Expression of monomorphic and polymorphic N-acetyltransferases in human colon. Biochem Pharmacol 1994;47:914-917.
25. Hickman D, Pope J, Patil SD, et al. Expression of arylamine N-acetyltransferase in human intestine. Gut 1998;42:402-409.
26. Windmill KF, Gaedigk A, Hall PM, Samaratunga H, Grant DM, McManus ME. Localization of N-acetyltransferases NAT1 and NAT2 in human tissues. Toxicol Sci 2000;54:19-29.
27. Hein DW, Rustan TD, Bucher KD, Furman EJ, Martin WJ. Extrahepatic expression of the N-acetylation polymorphism towards arylamine carcinogens in tumor target organs of an inbred rat model. J Pharmacol Exp Ther 1991;258:232-236.
28. 5 slow acetylator congenic mice. Drug Metab Dispos 1993;21:1057-1063.
29. Stanley LA, Mills IG, Sim E. Localization of polymorphic N-acetyltransferase (NAT2) in tissues of inbred mice. Pharmacogenetics 1997;7:121-130.
30. Sugamori KS, Wong S, Gaedigk A, et al. Generation and functional characterization of arylamine N-acetyltransferase Nat1/Nat2 double-knockout mice. Mol Pharmacol 2003;64:170-179.
31. Hein DW, Rustan TD, Bucher KD, Miller LS. Polymorphic and monomorphic expression of arylamine carcinogen N-acetyltransferase isozymes in tumor target organ cytosols of Syrian hamsters congenic at the polymorphic acetyltransferase locus. J Pharmacol Exp Ther 1991;259:699-704.
32. Hein DW, Doll MA, Rustan TD, Gray K, Ferguson RJ, Feng Y. Construction of Syrian hamster lines congenic at the polymorphic acetyltransferase locus (NAT2): Acetylator genotype-dependent N- and O-acetylation of arylamine carcinogens. Toxicol Appl Pharmacol 1994;124:16-24.
33. Hein DW. A new model for toxic risk assessments: Construction of homozygous rapid and slow acetylator congenic Syrian hamster lines. Toxicol Meth 1991;1:44-52.
34. Ferguson RJ, Doll MA, Rustan TD, Baumstark BR, Hein DW. Polymorphic arylamine N-acetyltransferase encoding gene (NAT2) from homozygous rapid and slow acetylator congenic Syrian hamsters. Gene 1994;140:247-249.
35. Leff MA, Epstein PN, Doll MA, et al. Prostate-specific human N-acetyltransferase 2 (NAT2) expression in the mouse. J Pharmacol Exp Ther 1999;290:182-187.
36. Fretland AJ, Doll MA, Zhu Y, Smith L, Leff MA, Hein DW. Effect of nucleotide substitutions in N-acetyltransferase-1 on N-acetylation (deactivation) and O-acetylation (activation) of arylamine carcinogens: Implications for cancer predisposition. Cancer Detect Prev 2002;26:10-14.
37. Xiao GH, Doll MA, Fretland AJ, Webb SJ, Hein DW. Recombinant expression of rat, hamster and mouse N-acetyltransferase 2 (NAT2) rapid and slow acetylator phenotypes in yeast. Proc Ninth North Amer ISSX Meeting 1999;15:130.
38. Ware JA, Svensson CK. Longitudinal distribution of arylamine N-acetyltransferases in the intestine of the hamster, mouse, and rat. Evidence for multiplicity of N-acetyltransferases in the intestine. Biochem Pharmacol 1996;52:1613-1620.
39. Hein DW, Kirlin WG, Ferguson RJ, Weber WW. Biochemical investigation of the basis for the genetic N-acetylation polymorphism in the inbred hamster. J Pharmacol Exp Ther 1985;234:358-364.
40. Smith TJ, Hanna PE. N-acetyltransferase multiplicity and bioactivation of N-arylhydroxamic acids by hamster hepatic and intestinal enzymes. Carcinogenesis 1986;7:697-702.
41. Trinidad A, Kirlin WG, Ogolla F, et al. Kinetic characterization of acetylator genotype-dependent and -independent N-acetyltransferase isozymes in homozygous rapid and slow acetylator inbred hamster liver cytosol. Drug Metab Dispos 1989;17:238-247.
42. Ozawa S, Abu-Zeid M, Kawakubo Y, Toyama S, Yamazoe Y, Kato R. Monomorphic and polymorphic isozymes of arylamine N-acetyltransferases in hamster liver: Purification of the isozymes and genetic basis of N-acetylation polymorphism. Carcinogenesis 1990;11:2137-2144.
43. Hein DW, Doll MA, Gray K, Rustan TD, Ferguson RJ. Metabolic activation of N-hydroxy-2-aminofluorene and N-hydroxy-2-acetylaminofluorene by monomorphic N-acetyltransferase (NAT1) and polymorphic N-acetyltransferase (NAT2) in colon cytosols of Syrian hamsters congenic at the NAT2 locus. Cancer Res 1993;53:509-514.
44. Yerokun T, Kirlin WG, Trinidad A, et al. Identification and kinetic characterization of acetylator genotype-dependent and -independent arylamine carcinogen N-acetyltransferases in hamster bladder cytosol. Drug Metab Dispos 1989;17:231-237.
45. Hein DW, Doll MA, Xiao GH, Feng Y. Prostate expression of N-acetyltransferase 1 (NAT1) and 2 (NAT2) in rapid and slow acetylator congenic Syrian hamster. Pharmacogenetics 2003;13:159-167.
46. Hein DW, Kirlin WG, Ogolla F, Trinidad A. Extrahepatic expression of N-acetylator genotype in the inbred hamster. Drug Metab Dispos 1987;15:68-73.
47. Hein DW, Flammang TJ, Kirlin WG, Trinidad A, Ogolla F. Acetylator genotype dependent metabolic activation of carcinogenic N-hydroxyarylamines by S-acetyl coenzyme A-dependent enzymes of inbred hamster tissue cytosols: Relationship to arylamine N-acetyltransferase. Carcinogenesis 1987;8:1767-1774.
48. Ogolla F, Ferguson RJ, Kirlin WG, et al. Acetylator genotype-dependent expression of arylamine N-acetyltransferase and N-hydroxy-arylamine O-acetyltransferase in Syrian inbred hamster intestine and colon: Identity with the hepatic acetylation polymorphism. Drug Metab Dispos 1990;18:680-685.
49. Fretland AJ, Devanaboyina US, Doll MA, Zhao S, Xiao GH, Hein DW. Metabolic activation of 2-hydroxyamino-1-methyl-6-phenylimidazo [4,5-b]pyridine in Syrian hamsters congenic at the N-acetyltransferase 2 (NAT2) locus. Toxicol Sci 2003;74:253-259.
50. Minchin RF, Reeves PT, Teitel CH, et al. N- and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferases expressed in COS-1 cells. Biochem Biophys Res Comm 1992;185:839-844.
51. Hein DW, Doll MA, Rustan TD, Ferguson RJ. Metabolic activation of N-hydroxyaryiamines and N-hydroxyarylamides by 16 recombinant human NAT2 allozymes: Effects of 7 specific NAT2 nucleic acid substitutions. Cancer Res 1995;55:3531-3536.
52. Feng Z, Hu W, Rom WN, Beland FA, Tang MS. 4-aminobiphenyl is a major etiological agent of human bladder cancer: Evidence from its DNA binding spectrum in human p53 gene. Cardnogenesis 2002;23:1721-1727.
53. Badawi AF, Bell DA, Hirvonen A, Kadlubar FF. Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder. Cancer Res 1995;55:5230-5237.
54. Kirlin WG, Trinidad A, Yerokun T, et al. Polymorphic expression of AcCoA-dependent arylamine N-acetyltransferase and AcCoA-dependent O-acetyltransferase activation of N-hydroxyarylamines by human bladder cytosol. Cancer Res 1989;49:2448-2454.
55. Anderson KE, Hammons GJ, Kadlubar FF, et al. Metabolic activation of aromatic amines by human pancreas. Carcinogenesis 1997;18:1085-1092.
56. Thompson PA, Seyedi F, Lang NP, et al. 1999. Comparison of DNA adduct levels associated with exogenous and endogenous exposures in human pancreas in relation to metabolic genotype. Mutat Res 1999;424:263-274.
57. Ricicki EM, Soglia JR, Teitel C, Kane R, Kadlubar F, Vouros P. Detection and quantification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl adducts in human pancreas tissue with capillary liquid chromatography-microelectrospray mass spectrometry. Chem Res Toxicol 2005;18:692-699.
58. Li D, Jiao L, Li Y, et al. Polymorphisms of cytochrome P4501A2 and N-acetyltransferase genes, smoking and risk of pancreatic cancer. Carcinogenesis 2005 (Epub ahead of print June 29, 2005). 239-249